These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15588796)

  • 1. GERD 2004: issues from the past and a consensus for the future.
    Modlin I; Kidd M
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():55-66. PubMed ID: 15588796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease.
    Armstrong D
    Curr Opin Pharmacol; 2005 Dec; 5(6):589-95. PubMed ID: 16214410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GERD 2003: issues from the past and a consensus for the future.
    Modlin I; Kidd M
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():3-8. PubMed ID: 15190381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey.
    Chey WD; Inadomi JM; Booher AM; Sharma VK; Fendrick AM; Howden CW
    Am J Gastroenterol; 2005 Jun; 100(6):1237-42. PubMed ID: 15929751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children.
    Hassall E
    J Pediatr; 2005 Mar; 146(3 Suppl):S3-12. PubMed ID: 15758900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
    Gold BD
    Am J Gastroenterol; 2006 Mar; 101(3):641-4. PubMed ID: 16542297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotherapy and surgery for GERD.
    Triadafilopoulos G
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2():S87-96. PubMed ID: 17575537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of esophageal pH monitoring in symptomatic patients on PPI therapy.
    Charbel S; Khandwala F; Vaezi MF
    Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and symptom control in patients with GERD: US community-based survey.
    Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
    Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastroesophageal reflux disease: therapeutic features (Part II)].
    Corinaldesi R; Salvioli B; Lioce A; Barbara G; Cremon C; Fustini E; Bini L; Cogliandro R; Boschi E; Felicani C; Stanghellini V; De Giorgio R
    Clin Ter; 2007; 158(2):165-72. PubMed ID: 17566520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pharmacological agents for the treatment of gastroesophageal reflux disease.
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):117-22. PubMed ID: 18641594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing compliance with long-term therapy: avoiding complications and adverse events.
    Vakil N
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():S12-7. PubMed ID: 16369223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.